Organisation paid for research Program year 2022 Source: CMS Open Payments

Bayside Clinical Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$526,889

14 payments

Through program year 2022, Bayside Clinical Research, LLC is reported as receiving $526,889 in research payments, across 14 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$1,560	1
2021	Research	$91,973	8
2020	Research	$167,123	3
2019	Research	$266,233	2

Breakdown

Who paid Research payments · program years 2019–2022

Eli Lilly and Company $526,889 14 payments

Studies the money was for Research payments · program years 2019–2022

A Randomized, Phase 3, Open-Label Trial Comparing the Effect of Ly3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes $475,070 6 payments
A Phase 2, Randomized, Parallel, Open-Label Comparator Controlled Trial to Evaluate the Safety and Efficacy of Ly3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy $51,535 4 payments
Anti-Amyloid Treatment in Asymptomatic Alzheimers Disease -A4 Study $90 1 payment
A Study of Tirzepatide (Ly3298176) Once A Week Versus Insulin Glargine Once A Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk $69 1 payment
A Randomized, Active-Controlled, Parallel-Group, Phase 3B/4 Study of Baricitinib in Patients With Rheumatoid Arthritis $65 1 payment
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Ly3041658 in Adults With Moderate-To-Severe Hidradenitis Suppurativa $60 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.